Brain metastasis radiotherapy;La radiothérapie des métastases cérébrales

Cancer/Radiotherapie

Volumn 10, Issue 6-7, 2006, Pages 437-443

  Noel, G ^a  

^a CENTRE PAUL STRAUSS   (France)

Author keywords

Brain metastasis; Radiosurgery; Stereotactic radiation therapy; Whole brain radiation therapy

Indexed keywords

CORTICOSTEROID; EFAPROXIRAL; FOTEMUSTINE; GADOLINIUM; GADOLINIUM TEXAPHYRIN; TEMOZOLOMIDE; TENIPOSIDE;

BRAIN METASTASIS; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; COGNITION; CORTICOSTEROID THERAPY; HUMAN; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIOSURGERY; SHORT SURVEY; STATISTICAL SIGNIFICANCE; STEREOTAXIC SURGERY; SURVIVAL TIME;

BRAIN NEOPLASMS; HUMANS; RADIOSURGERY; RADIOTHERAPY;

EID: 33750491061     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2006.07.019     Document Type: Short Survey

References (62)

1. Andrews D.W., Scott C.B., Sperduto P.W., Flanders A.E., Gaspar L.E., Schell M.C., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363 (2004) 1665-1672
2. Antonadou D., Paraskevaidis M., Sarris G., Coliarakis N., Economou I., Karageorgis P., et al. Phase II randomised trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J. Clin. Oncol. 20 (2002) 3644-3650
3. Aoyama H., Shirato H., Tago M., Nakagawa K., Toyoda T., Hatano K., et al. Stereotactic radiosurgery plus whole-brain radiation therapy versus stereotactic radiosurgery alone for treatment of brain metastases: a randomised controlled trial. JAMA 295 (2006) 2483-2491
4. Asai A., Matsutani M., Kohno T., Nakamura O., Tanaka H., Fujimaki T., et al. Subacute brain atrophy after radiation therapy for malignant brain tumor. Cancer 63 (1989) 1962-1974
5. Bindal A.K., Bindal R.K., Hess K.R., Hassenbusch S.J., Shi W.M., and Sawaya R. Surgery versus radiosurgery in the treatment of brain metastasis. J. Neurosurg. 84 (1996) 748-754
6. Borgelt B., Gelber R., Kramer S., Brady L.W., Chang C.H., Davis L.W., et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 6 (1980) 1-9
7. Borgelt B., Gelber R., Larson M., Hendrickson F., Griffin T., and Roth R. Ultra-rapid high-dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 7 (1981) 1633-1638
8. Chao J.H., Phillips R., and Nickson J.J. Roentgen-ray therapy of cerebral metastases. Cancer 7 (1954) 682-689
9. Chatani M., Matayoshi Y., Masaki N., and Inoue T. Radiation therapy for brain metastases from lung carcinoma. Prospective randomised trial according to the level of lactate dehydrogenase. Strahlenther. Onkol. 170 (1994) 155-161
10. Chatani M., Teshima T., Hata K., Inoue T., and Suzuki T. Whole brain irradiation for metastases from lung carcinoma. A clinical investigation. Acta Radiol. Oncol. 24 (1985) 311-314
11. Chitapanarux I., Goss B., Vongtama R., Frighetto L., De Salles A., Selch M., et al. Prospective study of stereotactic radiosurgery without whole brain radiotherapy in patients with four or less brain metastases: incidence of intracranial progression and salvage radiotherapy. J. Neuro-oncol. 61 (2003) 143-149
12. Chougule P.B., Burton-William M., Saris S., Zheng Z., Ponte B., Noren G., et al. Randomised treatment of brain metastases with gamma knife radiosurgery, whole brain radiotherapy or both. Int. J. Radiat. Oncol. Biol. Phys. 48 (2000) 113 (abstract)
13. Cox J.D., and Yesner R.A. Adenocarcinoma of the lung: recent results from the Veterans Administration Lung Group. Am. Rev. Respir. Dis. 120 (1979) 1025-1029
14. DeAngelis L.M., Currie V.E., Kim J.H., Krol G., O'Hehir M.A., Farag F.M., et al. The combined use of radiation therapy and lonidamine in the treatment of brain metastases. J. Neurooncol. 7 (1989) 241-247
15. DeAngelis L.M., Delattre J.Y., and Posner J.B. Radiation-induced dementia in patients cured of brain metastases. Neurology 39 (1989) 789-796
16. Delattre J.Y., Krol G., Thaler H.T., and Posner J.B. Distribution of brain metastases. Arch. Neurol. 45 (1988) 741-744
17. Eyre H.J., Ohlsen J.D., Frank J., LoBuglio A.F., McCracken J.D., Weatherall T.J., et al. Randomised trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to brain. A Southwest Oncology Group study. J. Neurooncol. 2 (1984) 325-330
18. Gaspar L., Scott C., Rotman M., Asbell S., Phillips T., Wasserman T., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int. J. Radiat. Oncol. Biol. Phys. 37 (1997) 745-751
19. Hagan N., Cirrincione C., and DeAngelis L.M. The role of radiotherapy after resection of single brain metastases from melanoma. Radiology 39 (1989) 262
20. Haie-Meder C., Pellae-Cosset B., Laplanche A., Lagrange J.L., Tuchais C., Nogues C., et al. Results of a randomised clinical trial comparing two radiation schedules in the palliative treatment of brain metastases. Radiother. Oncol. 26 (1993) 111-116
21. Harwood A.R., and Simson W.J. Radiation therapy of cerebral metastases: a randomised prospective clinical trial. Int. J. Radiat. Oncol. Biol. Phys. 2 (1977) 1091-1094
22. Horton J., Baxter D.H., and Olson K.B. The management of metastases to the brain by irradiation and corticosteroids. Am. J. Roentgenol. Radium Ther. Nucl. Med. 111 (1971) 334-336
23. Hoskin P.J., Crow J., and Ford H.T. The influence of extent and local management on the outcome of radiotherapy for brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 19 (1990) 111-115
24. Komarnicky L.T., Phillips T.L., Martz K., Asbell S., Isaacson S., and Urtasun R. A randomised phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int. J. Radiat. Oncol. Biol. Phys. 20 (1991) 53-58
25. Kondziolka D., Patel A., Lunsford L.D., Kassam A., and Flickinger J.C. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 45 (1999) 427-434
26. Kurtz J.M., Gelber R., Brady L.W., Carella R.J., and Cooper J.S. The palliation of brain metastases in a favourable patient population: a randomised clinical trial by the Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 7 (1981) 891-895
27. Lagerwaard F.J., Levendag P.C., Nowak P.J., Eijkenboom W.M., Hanssens P.E., and Schmitz P.I. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int. J. Radiat. Oncol. Biol. Phys. 43 (1999) 795-803
28. Lutterbach J., Cyron D., Henne K., and Ostertag C.B. Radiosurgery followed by planned observation in patients with one to three brain metastases. Neurosurgery 52 (2003) 1066-1073
29. Meert A.P., Paesmans M., Berghmans T., Martin B., Mascaux C., Vallot F., et al. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 1 (2001) 5
30. Mehta M.P., Rodrigus P., Terhaard C.H., Rao A., Suh J., Roa W., et al. Results from the phase III trial of motexafin gadolinium (MGd) in brain metastases. Proc. Am. Soc. Clin. Oncol. 21 (2002) 72a [abstract]
31. Mehta M.P., Rodrigus P., Terhaard C.H., Rao A., Suh J., Roa W., et al. Survival and neurologic outcomes in a randomised trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J. Clin. Oncol. 21 (2003) 2529-2536
32. Mehta M.P., Tsao M.N., Whelan T.J., Morris D.E., Hayman J.A., Flickinger J.C., et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 63 (2005) 37-46
33. Mornex F., Thomas L., Mohr P., Hauschild A., Delaunay M.M., Lesimple T., et al. A prospective randomised multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma. Melanoma Res. 13 (2003) 97-103
34. Muacevic A., Kreth F.W., Horstmann G.A., Schmid-Elsaesser R., Wowra B., Steiger H.J., et al. Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J. Neurosurg. 91 (1999) 35-43
35. Murray K.J., Scott C., Greenberg H.M., Emami B., Seider M., Vora N.L., et al. A randomised phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int. J. Radiat. Oncol. Biol. Phys. 39 (1997) 571-574
36. Noel G., Medioni J., Valery C., Boisserie G., Simon J.M., Cornu P., et al. Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer. Lung Cancer 41 (2003) 333-343
37. Noordijk E.M., Vecht C.J., Haaxma-Reiche H., Padberg G.W., Voormolen J.H., Hoekstra F.H., et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int. J. Radiat. Oncol. Biol. Phys. 29 (1994) 711-717
38. O'Neill B.P., Iturria N.J., Link M.J., Pollock B.E., Ballman K.V., and O'Fallon J.R. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 55 (2003) 1169-1176
39. Patchell R.A., Cirrincione C., Thaler H.T., Galicich J.H., Kim J.H., and Posner J.B. Single brain metastases: surgery plus radiation or radiation alone. Neurology 36 (1986) 447-453
40. Patchell R.A., and Regine W.F. The rationale for adjuvant whole brain radiation therapy with radiosurgery in the treatment of single brain metastases. Technol. Cancer Res. Treat. 2 (2003) 111-116
41. Patchell R.A., Tibbs P.A., Regine W.F., Dempsey R.J., Mohiuddin M., Kryscio R.J., et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomised trial. JAMA 280 (1998) 1485-1489
42. Patchell R.A., Tibbs P.A., Walsh J.W., Dempsey R.J., Maruyama Y., Kryscio R.J., et al. A randomised trial of surgery in the treatment of single metastases to the brain. N. Engl. J. Med. 322 (1990) 494-500
43. Phillips T.L., Scott C.B., Leibel S.A., Rotman M., and Weigensberg I.J. Results of a randomised comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. Int. J. Radiat. Oncol. Biol. Phys. 33 (1995) 339-348
44. Posner J.B. Management of central nervous system metastases. Semin. Oncol. 4 (1977) 81-91
45. Posner J.B. Management of brain metastases. Rev. Neurol. (Paris) 148 (1992) 477-487
46. Postmus P.E., Haaxma-Reiche H., Smit E.F., Groen H.J., Karnicka H., Lewinski T., et al. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy: a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J. Clin. Oncol. 18 (2000) 3400-3408
47. Postmus P.E., Smit E.F., Haaxma-Reiche H., van Zandwijk N., Ardizzoni A., Quoix E., et al. Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J. Clin. Oncol. 13 (1995) 660-665
48. Priestman T.J., Dunn J., Brada M., Rampling R., and Baker P.G. Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin. Oncol. (R. Coll. Radiol.) 8 (1996) 308-315
49. Regine W.F., Huhn J.L., Patchell R.A., St Clair W.H., Strottmann J., Meigooni A., et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int. J. Radiat. Oncol. Biol. Phys. 52 (2002) 333-338
50. Robinet G., Thomas P., Breton J.L., Lena H., Gouva S., Dabouis G., et al. Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe français de pneumocancérologie (GFPC) Protocol 95-1. Ann. Oncol. 12 (2001) 59-67
51. Schoggl A., Kitz K., Reddy C.A., Wolfsberger S., Schneider B., Dieckmann K., et al. Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases. Acta Neurochir. (Wien) 142 (2000) 621-626
52. Shirato H., Takamura A., Tomita M., Suzuki K., Nishioka T., Isu T., et al. Stereotactic irradiation without whole-brain irradiation for single brain metastasis. Int. J. Radiat. Oncol. Biol. Phys. 37 (1997) 385-391
53. Smalley S.R., Schray M.F., Laws Jr. E.R., and O'Fallon J.R. Adjuvant radiation therapy after surgical resection of solitary brain metastasis: association with pattern of failure and survival. Int. J. Radiat. Oncol. Biol. Phys. 13 (1987) 1611-1616
54. Sneed P.K., Lamborn K.R., Forstner J.M., McDermott M.W., Chang S., Park E., et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary?. Int. J. Radiat. Oncol. Biol. Phys. 43 (1999) 549-558
55. Sperduto P.W. A review of stereotactic radiosurgery in the management of brain metastasis. Technol. Cancer Res. Treat. 2 (2003) 105-109
56. Stea B., Suh J.H., Boyd A.P., Cagnoni P.J., and Shaw E. Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: determinants of response and its prognostic value for subsequent survival. Int. J. Radiat. Oncol. Biol. Phys. 64 (2006) 1023-1030
57. Tsao M.N., Lloyd N.S., and Wong R.K. Clinical practice guideline on the optimal radiotherapeutics management of brain metastases. BMC Cancer 5 (2005) 34
58. Ushio Y., Arita N., Hayakawa T., Mogami H., Hasegawa H., Bitoh S., et al. Chemotherapy of brain metastases from lung carcinoma: a controlled randomised study. Neurosurgery 28 (1991) 201-205
59. Vecht C.J., Haaxma-Reiche H., Noordijk E.M., Padberg G.W., Voormolen J.H., Hoekstra F.H., et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?. Ann. Neurol. 33 (1993) 583-590
60. Vogelbaum M.A., and Suh J.H. Resectable brain metastases. J. Clin. Oncol. 24 (2006) 1289-1294
61. White K.T., Fleming T.R., and Law E.R.J. Single metastasis to the brain: surgical treatment in 122 consecutive patients. Mayo Clin. Proc. 56 (1981) 424-428
62. Zimm S., Wampler G.L., Stablein D., Hazra T., and Young H.F. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 48 (1981) 384-394